The Development and Evaluation of Novel Patient Educational Material for a Variant of Uncertain Significance (VUS) Result in Hereditary Cancer Genes.

MLA

Cragun, Deborah, et al. “The Development and Evaluation of Novel Patient Educational Material for a Variant of Uncertain Significance (VUS) Result in Hereditary Cancer Genes.” Current Oncology (Toronto, Ont.), vol. 31, no. 6, June 2024, pp. 3361–78. EBSCOhost, https://doi.org/10.3390/curroncol31060256.

APA

Cragun, D., Dean, M., Baker, D., Kelley, M., Hooker, G., Weidner, A., Hunt, P., & Pal, T. (2024). The Development and Evaluation of Novel Patient Educational Material for a Variant of Uncertain Significance (VUS) Result in Hereditary Cancer Genes. Current Oncology (Toronto, Ont.), 31(6), 3361–3378. https://doi.org/10.3390/curroncol31060256

Chicago

Cragun, Deborah, Marleah Dean, David Baker, Meghan Kelley, Gillian Hooker, Anne Weidner, Paige Hunt, and Tuya Pal. 2024. “The Development and Evaluation of Novel Patient Educational Material for a Variant of Uncertain Significance (VUS) Result in Hereditary Cancer Genes.” Current Oncology (Toronto, Ont.) 31 (6): 3361–78. doi:10.3390/curroncol31060256.